Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.2037 | 0.994 | 1 |
Toxoplasma gondii | ornithine aminotransferase, mitochondrial precursor, putative | 0.029 | 0.1246 | 0.5 |
Echinococcus granulosus | Aminotransferase class III | 0.029 | 0.1246 | 1 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.2049 | 1 | 1 |
Onchocerca volvulus | 0.2049 | 1 | 1 | |
Echinococcus multilocularis | Aminotransferase class III | 0.029 | 0.1246 | 1 |
Schistosoma mansoni | ornithine--oxo-acid transaminase | 0.029 | 0.1246 | 1 |
Echinococcus multilocularis | ornithine aminotransferase | 0.029 | 0.1246 | 1 |
Mycobacterium leprae | PROBABLE ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRANSFERASE BIOA | 0.2037 | 0.994 | 1 |
Echinococcus multilocularis | ornithine aminotransferase | 0.029 | 0.1246 | 1 |
Plasmodium falciparum | ornithine aminotransferase | 0.029 | 0.1246 | 0.5 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.2037 | 0.994 | 1 |
Wolbachia endosymbiont of Brugia malayi | acetylornithine transaminase protein | 0.029 | 0.1246 | 0.5 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.2037 | 0.994 | 1 |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.2037 | 0.994 | 0.5 |
Plasmodium vivax | ornithine aminotransferase, putative | 0.029 | 0.1246 | 0.5 |
Brugia malayi | 4-aminobutyrate aminotransferase, mitochondrial precursor | 0.029 | 0.1246 | 0.1246 |
Mycobacterium ulcerans | hypothetical protein | 0.2037 | 0.994 | 1 |
Chlamydia trachomatis | glutamate-1-semialdehyde-2,1-aminomutase | 0.029 | 0.1246 | 0.5 |
Echinococcus granulosus | ornithine aminotransferase | 0.029 | 0.1246 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 37 % | Percent inhibition value on the Sephadex-induced lung eosinophilia model at an intraperitoneal (ip) dose of 3 mg/kg | ChEMBL. | 9685237 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.